Literature DB >> 23797612

Initial clinical findings of a mathematical model to predict survival of head and neck cancer.

Kevin S Emerick1, Erica R Leavitt, James S Michaelson, Bradford Diephuis, John R Clark, Daniel G Deschler.   

Abstract

OBJECTIVES: (1) Identify clinical features that impact survival for head and neck cancer. (2) Determine the individual contribution to mortality of significant clinical features. (3) Develop a web-based calculator to integrate clinical features and predict survival outcome for individual patients. STUDY
DESIGN: Analysis of a national cancer database. We fit patient data to the binary-biological model of cancer lethality, a mathematical model designed to predict cancer outcome. The model predicts the risk of cancer death, using information on tumor size, nodal status, and other prognostic factors. SUBJECTS AND METHODS: Analysis was carried out on a cohort of ~50,000 patients with head and neck cancer from the Survey, Epidemiology and End-Results (SEER) 2009 data set and validated with a cohort of ~1300 patients from an institutional Massachusetts General Hospital/Massachusetts Eye and Ear Infirmary database. We developed a web-based calculator written in JavaScript, PHP, and HTML.
RESULTS: The risk of death due to head and neck cancer increases monotonically with tumor size. Each positive lymph node is associated with ~14% extra risk of death. Anatomical site, age, race, tumor extension, N stage, and extracapsular spread contribute to mortality. The lethal impact of these prognostics factors can be accurately estimated by the Size + Nodes + PrognosticMarkers (SNAP) method.
CONCLUSIONS: This predictive cancer model and web-based calculator provide a basis for estimating the risk of death for head and neck cancer patients by assigning values to the lethal contributions of tumor size, number of positive nodes, anatomical site, tumor extension, N stage, extracapsular spread, age at diagnosis, and race.

Entities:  

Keywords:  calculator; head neck cancer; mathematical model; survival

Mesh:

Year:  2013        PMID: 23797612     DOI: 10.1177/0194599813495178

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  10 in total

1.  Time-varying survival effects for squamous cell carcinomas at oropharyngeal and nonoropharyngeal head and neck sites in the United States, 1973-2015.

Authors:  Andrew F Brouwer; Kevin He; Steven B Chinn; Alison M Mondul; Christina H Chapman; Marc D Ryser; Mousumi Banerjee; Marisa C Eisenberg; Rafael Meza; Jeremy M G Taylor
Journal:  Cancer       Date:  2020-09-05       Impact factor: 6.860

2.  Individualized risk prediction of outcomes for oral cavity cancer patients.

Authors:  Victoria Prince; Emily L Bellile; Yilun Sun; Gregory T Wolf; Connor W Hoban; Andrew G Shuman; Jeremy M G Taylor
Journal:  Oral Oncol       Date:  2016-11-23       Impact factor: 5.337

3.  Individualized outcome prognostication for patients with laryngeal cancer.

Authors:  Connor W Hoban; Lauren J Beesley; Emily L Bellile; Yilun Sun; Matthew E Spector; Gregory T Wolf; Jeremy M G Taylor; Andrew G Shuman
Journal:  Cancer       Date:  2017-11-07       Impact factor: 6.860

4.  Differences in predictions of ODE models of tumor growth: a cautionary example.

Authors:  Hope Murphy; Hana Jaafari; Hana M Dobrovolny
Journal:  BMC Cancer       Date:  2016-02-26       Impact factor: 4.430

5.  Prognostic Score Predicts Survival in HPV-Negative Head and Neck Squamous Cell Cancer Patients.

Authors:  Xu Qian; Duc T Nguyen; Yue Dong; Branko Sinikovic; Andreas M Kaufmann; Jeffrey N Myers; Andreas E Albers; Edward A Graviss
Journal:  Int J Biol Sci       Date:  2019-05-12       Impact factor: 6.580

6.  Epigenetic biomarkers of ageing are predictive of mortality risk in a longitudinal clinical cohort of individuals diagnosed with oropharyngeal cancer.

Authors:  Rhona A Beynon; Suzanne M Ingle; Ryan Langdon; Margaret May; Andy Ness; Richard M Martin; Matthew Suderman; Kate Ingarfield; Riccardo E Marioni; Daniel L McCartney; Tim Waterboer; Michael Pawlita; Caroline Relton; George Davey Smith; Rebecca C Richmond
Journal:  Clin Epigenetics       Date:  2022-01-03       Impact factor: 6.551

Review 7.  In vitro models as tools for screening treatment options of head and neck cancer.

Authors:  Barbara Seliger; Ahmed Al-Samadi; Bo Yang; Tuula Salo; Claudia Wickenhauser
Journal:  Front Med (Lausanne)       Date:  2022-09-07

Review 8.  Precision Medicine Gains Momentum: Novel 3D Models and Stem Cell-Based Approaches in Head and Neck Cancer.

Authors:  Annette Affolter; Anne Lammert; Johann Kern; Claudia Scherl; Nicole Rotter
Journal:  Front Cell Dev Biol       Date:  2021-07-08

9.  Molecular imaging of oral premalignant and malignant lesions using fluorescently labeled lectins.

Authors:  John Baeten; Amritha Suresh; Alexander Johnson; Ketan Patel; Moni Kuriakose; Anita Flynn; Deepak Kademani
Journal:  Transl Oncol       Date:  2014-03-04       Impact factor: 4.243

10.  Development and Assessment of a Model for Predicting Individualized Outcomes in Patients With Oropharyngeal Cancer.

Authors:  Lauren J Beesley; Andrew G Shuman; Michelle L Mierzwa; Emily L Bellile; Benjamin S Rosen; Keith A Casper; Mohannad Ibrahim; Sarah M Dermody; Gregory T Wolf; Steven B Chinn; Matthew E Spector; Robert J Baatenburg de Jong; Emilie A C Dronkers; Jeremy M G Taylor
Journal:  JAMA Netw Open       Date:  2021-08-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.